Severe atopic dermatitis drug sees positive study results
Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and  drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Breakthru Medicine emerges from stealth to develop cancer drugs
FDA Rare Pediatric Disease designation for mucopolysaccharidosis Type II treatment
CIRM approves $100m plan to accelerate genetic therapies for patients with rare diseases
Researchers develop more reliable platform to test antibody medicines
Positive topline results from acne study
Sarbecovirus vaccine trial starts
Vetter Pharma to build new manufacturing site in Germany
New dementia treatment strategy proposed